US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Women's Health Market Research Reports & Industry Analysis

Women’s health is a perspective of prevention and treatment that looks at health concerns unique to females. Even though slightly more than half of the US population is female, medical research historically has neglected the health needs of women, other than reproductive issues. Recently there have been major changes in government and private support of women’s health research -- in policies, regulations, and the organization of research efforts.
In a recent Institute of Medicine (IOM) report, the Washington DC-based institute found that women’s health research has contributed to significant progress over the past 20 years in lessening the burden of disease and reducing deaths from some conditions for women, while other conditions have seen only moderate change or even little or no change. Gaps remain, both in research areas and in the application of results to benefit women in general and across multiple population groups.

Viewing women’s health exclusively as a function of sex differences is too narrow, according to the IOM report. It frames women’s health and well-being as a function only of biological factors and how they differ in men and women, and ignores the role of gender, which is affected by broader social and community factors. The IOM finds that there has been inadequate attention paid to the social and environmental factors that, along with biologic risk factors, influence women’s health. Although progress has been made in identifying behavioral determinants of women’s health, such as smoking, diet, and physical activity, few studies have tested ways to modify these determinants in women or examined the effects of social and community factors in specific groups of women. To advance this area of research, the IOM recommends that the National Institutes of Health (NIH) support research on common determinants and risk factors that underlie multiple diseases.

Significant progress has been made in reducing mortality for women from breast cancer, cardiovascular disease and cervical cancer. This can be attributed in part to increased consumer demand and awareness, which has resulted in additional funding and research; improved diagnosis; screening and treatment; and, in the case of cervical cancer, a vaccine.

RSS Feeds

Women's Health Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Global Prenatal & Maternal Diagnostic Market To 2020
2/1/2016 | published by: Kelly Scientific Publications
... is causative of a specific disease. Since 2011, the launch of noninvasive prenatal tests (NIPTs) is revolutionizing the prenatal screening industry providing detection rates of >99% and false positive rates of Globally, 50 countries have ...  |  read more...
USD 3,800
Global Cervical Cancer Partnering 2010 to 2016
2/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Battery-powered Breast Pumps Industry 2016 Market Research Report
1/18/2016 | published by: QYResearch Group
... the industry including definitions, classifications, applications and industry chain structure. The Battery-powered Breast Pumps market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development ...  |  read more...
USD 2,800
Global Breast Cancer Partnering 2010 to 2016
2/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Sexual Dysfunction Partnering 2010 to 2016
2/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Ovarian Cancer Partnering 2010 to 2016
2/1/2016 | published by: Current Partnering
... Deals listed by company A-Z, industry sector, stage of development, technology type The report provides understanding and access to the partnering deals and agreements entered into by the world’s leading healthcare companies. The report provides ...  |  read more...
USD 1,495
Global Battery-powered Breast Pumps Consumption 2016 Market Research Report
1/25/2016 | published by: QYResearch Group
... the Battery-powered Breast Pumps industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures. Secondly, the report states the global Battery-powered ...  |  read more...
USD 4,000
Global and Chinese Breast Implant Industry, 2016 Market Research Report
1/20/2016 | published by: Prof-Research
... market. The report provides key statistics on the market status of the Breast Implant manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides ...  |  read more...
USD 2,900
Global Breastfeeding Pump Industry 2016 Market Research Report
1/18/2016 | published by: QYResearch Group
... including definitions, classifications, applications and industry chain structure. The Breastfeeding Pump market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development policies and plans ...  |  read more...
USD 2,800
Breast Cancer - Pipeline Review, H2 2015
12/31/2015 | published by: Global Markets Direct
... therapeutic development for Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,500
Endometriosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... objective of the Endometriosis Report is to understand the market and pipeline status of the drugs around the Endometriosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ...  |  read more...
USD 2,000
Female Sexual Dysfunction-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... A key objective of the Female Sexual Dysfunction Report is to understand the market and pipeline status of the drugs around the Female Sexual Dysfunction to explore the generic development opportunities, licensing opportunities and to ...  |  read more...
USD 2,000
Hormone Refractory Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... globe. A key objective of the Hormone Refractory Breast Cancer Report is to understand the market and pipeline status of the drugs around the Hormone Refractory Breast Cancer to explore the generic development opportunities, licensing ...  |  read more...
USD 2,000
Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... A key objective of the Metastatic Breast Cancer Report is to understand the market and pipeline status of the drugs around the Metastatic Breast Cancer to explore the generic development opportunities, licensing opportunities and to ...  |  read more...
USD 2,000
Uterine Fibroids-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016
1/1/2016 | published by: DelveInsight
... key objective of the Uterine Fibroids Report is to understand the market and pipeline status of the drugs around the Uterine Fibroids to explore the generic development opportunities, licensing opportunities and to gain competitive advantage ...  |  read more...
USD 2,000
Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015
12/30/2015 | published by: GlobalData
... (Pelvic Infections) clinical trials scenario. This report provides top line data relating to the clinical trials on Pelvic Inflammatory Disease (Pelvic Infections). Report includes an overview of trial numbers and their average enrollment in top ...  |  read more...
USD 2,500
Global Breast Localization Wire Industry 2016 Market Research Report
1/13/2016 | published by: QYResearch Group
... the industry including definitions, classifications, applications and industry chain structure. The Breast Localization Wire market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status. Secondly, development ...  |  read more...
USD 2,800
Ovarian Cancer - Pipeline Review, H2 2015
12/31/2015 | published by: Global Markets Direct
... therapeutic development for Ovarian Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,500
Epithelial Ovarian Cancer-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Post Menopausal Disorder-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Post Menopausal Osteoporosis-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Labor And Delivery-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ...  |  read more...
USD 1,250
Netherton Syndrome (Trichorrhexis Invaginata, Bamboo Hair)-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, ...  |  read more...
USD 1,250
Primary Dysmenorrhea-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Uterine Cancer-Pipeline Insights, 2016
1/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10